Isosceles Pharmaceuticals is an preclinical stage biotech developing a perioperative acute pain product candidates using actives with an approved drug master file and an excellent safety profile.
Company Details
- Employees
- 11
- Address
- 1213 Culbreth Dr, Wilmington,north Carolina 28405,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- isoscelespharma.com
- Keywords
- Non-Opioid, Medicine, Pain Therapy, Acute Pain, Opioid Crisis, Analgesia, Postoperative Pain, Intravenous, Transdermal, FDA, Non NSAID, Addiction Medicine, Inflammatory Disease, Clinical Development, Biotech, Small Molecule, Global Health, Unmet Need.
- HQ
- Wilmington, North Carolina
Isosceles Pharmaceuticals Questions
Isosceles Pharmaceuticals's website is isoscelespharma.com
Isosceles Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/isosceles-pharmaceuticals
Isosceles Pharmaceuticals has
11 employees.
View email and phone details for 11
employees at Isosceles Pharmaceuticals.
Isosceles Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Isosceles Pharmaceuticals's top competitors are
Noramco™,
Mallinckrodt Pharmaceuticals,
North Carolina Biotechnology Center (Ncbiotech),
Dermavant Sciences, An Organon Company,
Lindy Biosciences, Inc.,
Lenz Therapeutics,
Merakris Therapeutics, Inc.,
Alcami Corporation,
Plakous Therapeutics,
Medpharm.
Isosceles Pharmaceuticals's categories are Pharmaceutical Manufacturing
